Literature DB >> 11284945

In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.

M Venditti1, M Monaco, A Micozzi, A Tarasi, A Friedrich, P Martino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11284945

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  3 in total

1.  Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).

Authors:  Diana Averbuch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Christina Orasch; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

Review 2.  New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies.

Authors:  Sara Lo Menzo; Giulia la Martire; Giancarlo Ceccarelli; Mario Venditti
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-07-01       Impact factor: 2.576

3.  Fatal hemorrhagic pneumonia: Don't forget Stenotrophomonas maltophilia.

Authors:  Cristina Gutierrez; Egbert Pravinkumar; Dave Balachandran; Virginia Schneider
Journal:  Respir Med Case Rep       Date:  2016-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.